Summary Introduction
Epidemiological investigations are used to identify outbreaks, collect data, and implement control measures, playing a crucial role in disease control and prevention. Mathematical and statistical approaches enhance these investigations by incorporating data analysis to understand disease characteristics and provide insights.
Methods To estimate the transmissibility of a disease, we introduce a process to derive the likelihood function using individual patient information from epidemiological investigation. This method was applied to the case of Pyeongtaek St. Mary’s Hospital during the 2015 Middle East Respiratory Syndrome outbreak in Korea. A stochastic model was developed, and scenario analysis reflecting actual outbreak progress, risk factors, and mask mandates was conducted.
Results We applied transmission rate estimation to the Pyeongtaek St. Mary’s Hospital case, showing a high patient-to-patient transmission rate. The superspreader was observed to have approximately 25 times higher transmissibility than other patients. Given these conditions, if hospital transmission period is prolonged, number of cases could be three times higher than the actual incidence. The effect of mask-wearing in hospital was investigated based on the type of mask and the intensity of the intervention. It was found that the scale of epidemic could be reduced by a maximum of 77% and a minimum of 17%.
Conclusions Through the application of mathematical and statistical methodologies in epidemiological investigations, this study identified and quantified risk factors. Methodology of this study can be easily adapted and applied to other diseases and is expected to help in establishing effective strategies to fight against emerging infectious diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the Government-wide R&D Fund Project for Infectious Disease Research (GFID), Republic of Korea (grant No. HG23C1629). This paper is supported by the Korea National Research Foundation (NRF) grant funded by the Korean government (MEST) (NRF-2021R1A2C100448711).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
